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Mounting evidence confirms that hepatic biosynthetic processes are essential for female sexual
maturation in fish,which isdirectycontrolled byestrogens. These oogeneticevents (zonagenesis
andvitellogenesis) are induced inboth sexes byestrogens. In this paper, we report the induction
of zona radiata (zr) proteins and vitellogenin in primary hepatocytes from Atlantic salmon
(Saoh saar.L) exposed toxenoestrogens andmycotoxins. Cells were treatedwith doses of1, 5,
and 10 FM4-nonyiphenol (4-NP), oep'-DDT, lindane (y-HCH), and bisphenolA (BPA), which
all induced zrproteins andvitellogenin in an approximate dose-dependent manner. Hepatocytes
werealso treatedwithcombinations ofxenoestrogens at 1 or 2 pM, resulting in elevatedlevels of
both zr proteins and vitellogenin, compared to single treatment. The estrogenic activity ofthe
mycotorin zearalenone (ZEA) and its metabolites [a-zearalenol (a-ZEA) and P-zearalenol (P-
ZEA)], with.regard to zonagenesis and vitellogenesis, was assessed in this assay system.
Mycotoxins were used at concentrations of 10, 100, or 1,000 nM. All induced zr proteins and
vitellogenin, with a-ZEA being the strongest inducer. When cells were treated with xenoestro-
gens or mycotoxins in combination with an estrogen receptor inhibitor (ICI 182,780), the
induction of both zr proteins and vitellogenin was inhibited in all cases. Thus, the reported
estrogen effects are bonafide estrogen responses. Zona radiata proteins were more responsive
than viteogin to both xenoestrogens and mycotoxins. The versatility and sensitivity ofthe
hepatocrte assay demonstrates that biosynthesis of zr proteins provides a new supplementary
method for estaing xenoesrgenicity and mycotoxin action. Key words. eggshell, environ-
mental chemicals, hepatocytes, mycotoxin, zeamalenone, zonagenesis, zona radiata proteins.
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During sexual maturation in fish, ovarian
estrogen is transported in the blood to the
liver, where it induces biosynthetic processes
essential for the development of oocytes.
These processes are induced in both sexes fol-
lowing estradiol treatment, which simplifies
studies ofxenoestrogenicity. Vitellogenin is a
lipoglycophosphoprotein normally synthe-
sized bythe liver offemale fish in response to
17,B-estradiol (E2) (1,2) and transported in
the blood to the ovaries, where it serves as an
energy source for the developing embryo (3).
Like vitellogenin, synthesis of eggshell pro-
teins (zona radiata proteins or zr proteins) is
mediated by E2 in the liver (4). Recently, we
showed that hepatocytes from Atlantic
salmon synthesize both vitellogenin and zr
proteins when treated with E2 in vitro, and
importantly, zrproteinswere more responsive
than vitellogenin to E2 (5). Furthermore, in
fish exposed to environmental estrogens, zr
proteins were induced differently than vitel-
logenin (6C),.
A number ofenvironmental pollutants
are known to disturb the endocrine system of
animals, including fish and humans (8).
These chemicals, often termed endocrine dis-
ruptors, may impair fertility in a wide range
ofwildlife species, indudingfish (9), amphib-
ians (10), birds (11), and mammals (12).
Several in vitroassays have been established to
identify and assess suspected xenoestrogens.
These include studies of estrogen receptor
(ER) binding, cell proliferation, estrogen
responsive element-regulated reporter genes,
and yeast-based assays (13). Previous studies
estimating the xenoestrogen activity ofenvi-
ronmental chemicals measured the expres-
sion ofvitellogenin in rainbow trout hepato-
cyte cultures (14,15). In such experiments it
has been demonstrated that 4-nonylphenol
(4-NP), octylphenol, o,p'-DDT, Aroclor
1221, and bisphenol A (BPA) induced vitel-
logenesis or vitellogenin expression (or pro-
duction) and that a mixture ofall chemicals
elevated the level ofvitellogenin compared
to treatmentwith thechemicalssingly (16).
In addition to synthetic chemicals, sev-
eral toxins produced by fungi may have an
adverse effect(s) on humans and animals.
One ofthese is the mycotoxin zearalenone
(ZEA), which is produced by different
strains of Fusarium, a frequently encoun-
tered contaminant in cereals and other
plant products (17,18). Katzenellenbogen
et al. (19) reported that ZEA mycotoxins
compete with estradiol for binding to the
cytoplasmic ER. ZEA causes reproductive
problems in farm animals due to its estro-
genic activity (17), and in some animal
models, ZEA is thought to be a primary
initiator of hepatic tumors (20). ZEA
undergoes metabolic reduction to the more
estrogenic zearalenols (21). The estrogenic
action greatly depends on the stereochemi-
cal (a, j) configuration of the hydroxyl
group in the nonaromatic moiety of their
structures (Fig. 1), and a-ZEA is about
three times more estrogenic than ZEA (22).
It is ofinterest to test ZEA in a fish model
since a previous study reported a reduced
number and quality ofspermatozoa in carp
following ZEA exposure (23).
Hepatocytic in vitro synthesis of vitel-
logenin provides a useful and rapid assess-
ment of xenoestrogenic potentials (16).
However, zr proteins were recently found to
be more sensitive to E2 (5) andxenoestrogens
than vitellogenin (6,7). The availability of
specific antibodies to oocytic proteins has
enabled documentation, both in vivo and in
vitro, of initiation of oogenesis after either
estrogenic or xenoestrogenic induction. To
our knowledge, the relative potency of ZEA
and its a and ,B metabolites has so far not
been directly evaluated. Thus, it is ofinterest
to compare their estrogenic potentials with
respect to zr protein biosynthsis. In vitro
estrogenic potencies of 4-NP, o,p'-DDT,
BPA, lindane (y-HCH), and ZEA mycotox-
ins (see Fig. 1) were studied using primary
hepatocyte cultures from Atlantic salmon.
The aim ofthis studywas to evaluate the rela-
tive merits of zr proteins and vitellogenin
biosynthesis in assessing the estrogenic poten-
tials ofenvironmental chemicals and myco-
toxins by an in vitrocellular assay.
Materials and Methods
Chemicals. 4-Chloro-1-naphthol tablets, o-
phenylenediamine dihydrochloride (OPD),
EGTA, HEPES, bovine serum albumin
(BSA), ZEA, a-ZEA, [-ZEA, and BPAwere
purchased from Sigma Chemical Company
(St. Louis, MO). op'-DDT was purchased
from Promochem AB (Ulricehamn,
Sweden); 4-NP (85% p-isomers) was from
Fluka, (Buchs, Switzerland), and lindane
was from Riedel-deHaen (Seelze, Germany).
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Other chemicals and secondary antibodies
for ELISA analysis were from Bio-Rad
Laboratories (Hercules, CA). The mono-
clonal antibody against salmon vitellogenin
(BN-5 and KB-1) was purchased from
Biosense Laboratories (Bergen, Norway).
Dulbecco's modified Eagle's medium
(DMEM), fetal bovine serum (FBS), gluta-
mine, and antibiotic/antimycotic solution
(AAS) were obtained from Gibco BRL (Life
Technologies Ltd., Paisley, UK). Primaria
plates for cell cultures were from Falcon
(Becton Dickinson Labware, Oxnard, CA).
ICI 182,780 was a gift from B. Vose,
Zeneca Pharmaceuticals (Macclesfield,
UK). Other chemicals were ofhighest com-
mercial purity.
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Collagenaseperfusion ofliver. Hepato-
cytes were isolated from male or juvenile
Atlantic salmon (Sxvareid fish farm, Fusa,
Norway) by a two-step perfusion method of
Berry and Friend (24), as modified for fish
by Andersson et al. (25). The liver was per-
fused using a peristaltic pump at a flow rate
of22 ml/min. First, the liverwas perfused in
situ for 10 min with a calcium-free solution
containing NaCI (7.14 g/l), KC1 (0.36 g/l),
MgSO4 (0.15g/1), Na2HPO4 (1.6 g/l),
NaH2PO4 (0.4 g/l), NaHCO3 (0.31 g/l),
and EGTA (20 mg/l) at ambient tempera-
ture until all blood had been washed out.
The whitened liver was then perfused in situ
for approximately 10 min in the same
buffer, but containing calcium (0.22 g/l)
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Figure 1. Chemical structures ofthe different compounds used in the study.
instead of EGTA, and collagenase 80
mg/150 ml. All glassware and instruments
were autoclaved before use. Solutions were
sterilized by filtration using 0.22 pm
Millipore filter (Millipore AB, Sundbyberg,
Sweden).
Preparation andtreatmentofhepatocyte
cultures. After perfusion, the liver was dis-
persed in the calcium-containing buffer sup-
plemented with BSA (0.1 g/100 ml). The
suspension was filtered through a 150-mm
nylon monofilament filter and centrifuged
at 50g for 2 min. Cells were washed with
medium three times and finally resuspended
in medium. Viability ofhepatocytes used for
experiments was always over 90%, as deter-
mined by Trypan blue exclusion. After mea-
suring cell yield, cells were plated on 24-well
multiwell Primaria plates (=0.5 x 106 cells
per well) in DMEM (without phenol red)
containing 0.5% (v/v) FBS, 15 mmol/l
HEPES, glutamine (0.3 g/l medium) and
AAS (1,000 units/l pencillin, 1 pg/ml strep-
tomycin, and 0.75 pg/ml amphotericin).
Cells were kept at a constant temperature of
10.0°C (± 0.5) in ambient atmosphere.
After plating, the cells were cultured for 2
days in medium without test compounds.
Medium was then removed and replaced by
medium containing environmental chemi-
cals or mycotoxins. Medium was changed
every day for 4 days. Cells were treated with
different doses of the test chemicals 4-NP,
o,p'-DDT, y-HCH, and BPA, all in con-
centrations of1, 5, and 10 1iM. Hepatocytes
were treated with each chemical alone (5
pM) or in combination with the ER
inhibitor ICI 182,780 (1 pm). Cells were
also treated with a mixture of all chemicals
in concentrations of 1 pM (mixture 1) and 2
pM (mixture 2) alone and in combination
with 1 pM ICI 182,780. Furthermore,
hepatocytes were treated with the mycotoxin
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Figure 2. Induction of (A) zona radiata proteins and (B) vitellogen in hepatocytes after treatment with 1, 5, and 10 pM 4-nonylphenol (4-NP), o,p'-DDT, lindane (Y-
HCH), or bisphenol A (BPA) as measured by the enzyme-linked immunosorbent assay (ELISA). Zona radiata proteins were measured after 48 hr exposure, and
vitellogenin was measured after 96 hr exposure. Data are given as means ± standard deviations oftriplicate cell treatments.
*p<0.01; **p<0.001.
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ZEA and its metabolites, ax-ZEA and ,B-
ZEA, alone or in combination with ICI
182,780. Hepatocytes were treated with
increasing concentrations: 10, 100, and
1,000 nM of each compound. When cells
were incubated with ICI 182,780 in combi-
nation with mycotoxins, a concentration of
1 pM of the inhibitor was used with 100
nM a-ZEA or with 1,000 nM ZEA or -
ZEA. All compounds were solubilized in
absolute ethanol, and the amount ofethanol
in medium did notexceed 0.1% oftotal vol-
ume. Control cells were treated with medi-
um containing 0.1% ethanol. Cell treatment
studies were repeated in triplicate, and
experiments were repeated with primary cell
preparations from three fish.
Antiserum preparation and specificity.
Antiserum to zr proteins from Atlantic
salmon was prepared according to Rong
(26) as follows: zr proteins collected from
plasma were purified by preparative SDS
polyacrylamide gel electrophoresis (PAGE),
and a polyclonal antiserum that recognized
all three zr proteins was raised in rabbit.
The specificity ofthe polyclonal antiserum
was checked by Western blotting, and no
cross-reactivity with purified vitellogenin
orother plasma proteins was seen (4,27).
ELISA analysis. The enzyme-linked
immunosorbent assay (ELISA) was based on
the method of Oppen-Berntsen et al. (28),
except that nonspecific protein binding to
the wells was blocked using 2% BSA (200
pl). The wells were incubated with 100 pl
polyclonal antiserum against zr proteins,
diluted 1:1000 in 1% BSA, or 100 pl mon-
oclonal antibody against vitellogenin (KB-1
or BN-5) at a concentration of 1:500 in 1%
BSA. Secondary antibodies were goat anti-
rabbit IgG horseradish peroxidase conjugate
(1:3000) and goat anti-mouse IgG horserad-
ish peroxidase (1:3000). Absorbance was
measured at492 nm. Samples containing all
reagents except antigen were used to mea-
sure background values of the antibodies.
This absorbance value was then subtracted
from all measurements.p-Values were calcu-
lated by comparing each treatment to con-
trol (t-test; Microsoft Excel 5.0; Microsoft,
Redmond, WA).
Results
Hepatocytes were treated with increasing
amounts (1, 5, and 10 pM) of4-NP, o,p'-
DDT, y-HCH, or BPA. All chemicals
induced zr proteins in an approximate
dose-dependent manner after 48 hr of
treatment (Fig. 2A). At this time of expo-
sure vitellogenin was not detected.
However, after 96 hr of treatment, vitel-
logenin did show a delayed but similar
dose-dependent induction (Fig. 2B).
Figure 3 presents the induction ofhepa-
tocytic production of zr proteins and vitel-
logenin after in vitro treatment with differ-
ent xenobiotics. A time-dependent induc-
tion of both zr proteins and vitellogenin
was found when cells were treated with 5
pM ofeither 4-NP, o,p'-DDT, y-HCH, or
BPA. Zr proteins were detected in the cul-
ture medium 48 hr before vitellogenin.
Figure 4 shows the effect ofmixtures of
the various compounds compared to indi-
vidual treatment. Analysis of zr proteins in
medium after 48 hr ofexposure showed eler
vated levels of zr proteins when cells were
treated with mixtures of chemicals com-
pared to treatment with individual com-
pounds (Fig. 4A). Additionally, the level of
zr proteins was elevated after treatment with
the 2 pM mixture of chemicals, as com-
pared to treatment with the 1 pM mixture
ofthe same chemicals. However, after 96 hr
exposure, the response was maximal both
for o,p'-DDT and BPA alone, so that treat-
ment of cells with mixtures of 1 pM or 2
pM appears not to elevate the levels of zr
proteins in terms of a relative ELISA
response (Fig. 4B). Vitellogenin was not
induced after 48 hr of exposure. However,
when medium was analyzed after 96 hr,
induction ofvitellogenin was elevated after
treatment with both 1 pM and 2 pM mix-
tures, compared to individual treatment
(Fig. 4C). Additionally, treatment ofhepa-
tocytes with a mixture of2 pM ofall chem-
icals resulted in stronger induction than was
seen for cells treatedwith the 1 pM mixture
(Fig4C).
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Figure 3. Time-course of induction of (A) zona
radiata proteins and (B) vitellogenin after treat-
ment of hepatocytes with 5 pM 4-nonylphenol (4-
NP), o,p'-DDT, lindane (y-HCH), or bisphenol A
(BPA). Media were sampled and analyzed by
enzyme-linked immunosorbent assay (ELISA)
every 24 hr. Data are given as means oftriplicate
cell treatments.
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Figure 4. Induction of zona radiata proteins in hepatocytes after
48 hr(A) and after 96 hr(B), and induction ofvitellogenin after 96
hr (C), as measured by the enzyme-linked immunosorbent assay
(ELISA). Cells were treated with a single 1 pM dose of 4-
nonylphenol (4-NP), o,p'-DDT, lindane (y-HCH), or bisphenol A
(BPA), and with mixtures of 1 pM (Mix 1) and 2 pM (Mix 2) ofthe
different chemicals. Data are given as means ± standard devia-
tions oftriplicate celltreatments.
pc0.01; "c.001.
Environmental Health Perspectives * Volume 107, Number 1, January 1999
-g
E
a
U
U C94
am1
*1
I
C
1.2
1
0.8 i}
0.4
0.2
0
0.6
0.4 C
0.3 I,
0.2
0
65Articles * Celius et al.
Z .h =
cr
i;. . .S.
_.- -^ E
0.12
0.1
0.08
0.06
0.04
0.02
4 + + + =
CL a.. b-
4 I=
CL
Treatment Tretment
Figure 5. Induction of (A) zona radiata proteins and (B) vitellogenin measured by enzyme-linked immunosorbent assay (ELISA) after 96 hr of treatment with 5 pM
4-nonylphenol (4-NP), o,p'-DDT lindane (y-HCH), or bisphenol A (BPA) alone or in combination with 1 pM ICI 182,780. Data are given as means ± standard devia-
tions oftriplicate cell treatments.
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Figure 6. Induction of zona radiata proteins in medium from hepatocytes
treated with 10, 100, and 1,000 nM (A) zearalenone (ZEA), (B) a-zearalenol
(a-ZEA), and (C) P-zearalenol (J3-ZEA) measured by enzyme-linked
immunosorbent assay (ELISA) after 96 hr of treatment. Cells were also treat-
ed with 1 pM ICl 182,780 in combination with 100 nM ax-ZEA, orwith 1,000 nM
3-ZEA or ZEA. Data are given as means + standard deviations oftriplicate
cell treatments.
*p<.01; **p<0.001.
Discussion
Hepatocytes were also treated with
environmental chemicals in combination
with ICI 182,780, resulting in inhibition
of the induction of both zr proteins (Fig.
5A) and vitellogenin (Fig. 5B) at the con-
centrations used (5 pM of the various
chemicals and 1 pM ofthe inhibitor).
Cells were treated
with ZEA and its two
metabolites, a-ZEA
and ,B-ZEA, in 10, 100
and 1,000 nM concen-
trations. ax-ZEA was a
strong inducer of both
zr proteins (Fig. 6) and
vitellogenin (Fig. 7)
measured at 96 hr
exposure. Vitellogenin
was induced in a dose-
dependent manner in
contrast to zr proteins,
which showed similar
(almost maximal) in-
duction at the lowest
concentration of a-
ZEA. ZEA and [-ZEA
also induced synthesis
of zr proteins and vitel-
logenin, but to a lower
extent. Hepatocytes
treated with a combi-
nation of mycotoxins
and ICI 182,780 re-
sulted in inhibition of
both zr proteins and
vitellogenin at the con-
centrations used (Fig. 6
and 7). However, only
a partial inhibition was
obtained for ax-ZEA in
such experiments.
Induction of zr proteins and vitellogenin
was previously observed after treatment of
primary hepatocyte cultures with E2 in
vitro (5). Therefore, use ofthis culture sys-
tem as an assay for estrogenicity was inves-
tigated with respect to environmental
chemicals and mycotoxins. Individual
xenobiotics exhibited varying estrogenicity
as assessed by this assay, and the results
show that zr proteins were more responsive
than vitellogenin to both xenoestrogens
and mycotoxins. Importantly, ICI 182,780
inhibited synthesis of both zr proteins and
vitellogenin in hepatocytes induced by any
of the tested environmental chemicals
(singly or in a mixture) or mycotoxins.
Hence, this assay system measures estro-
genicity ofchemicals.
Results from the present work corre-
spond with previous studies showing dose-
dependent induction ofvitellogenin, when
hepatocytes from rainbow trout were treat-
ed with increasing amounts of 4-NP,
octylphenol, Aroclor 1221, or BPA (16).
Sumpter and Jobling (16) reported that
hepatocytes treated with 1 and 5 pM o,p'-
DDT had increasing levels ofvitellogenin,
while a dose of 10 1IM decreased the level
significantly (16). They concluded that 10
pM o,p'-DDT was cytotoxic to the cells.
Our study shows increasing levels of both
zr proteins and vitellogenin after treatment
of cells with 10 pM o,p'-DDT; however,
we have seen a decrease in zr proteins and
vitellogenin levels after treatment with 10
pM o,p'-DDT in some experiments
(unpublished observation). The DDT con-
centrations used may be close to the cyto-
toxicological limit for the hepatocytes,
which may explain the variations between
the two in vitro studies.
Sumpter and Jobling (16) reported that
mixtures ofenvironmental chemicals elevat-
ed the levels of vitellogenin secreted from
hepatocytes exposed to a mixture ofchemi-
cals compared to exposure to a single chem-
ical. Our results match the results from
their report and extend the usefulness as
well as the sensitivity of this cellular assay
for estrogenicity. After 48 hr of exposure,
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hepatocytes treated with mixtures ofchemi-
cals (1 pM or 2 gM) had elevated levels of
zr proteins compared to those treated with a
single compound. In contrast, no vitel-
logenin was detected at this time (see Fig.
3). However, the level ofvitellogenin after
96 hr of exposure did exhibit approximate
dose dependency with respect to the com-
pounds tested and also showed higher
induction when cells were treated with a
mixture ofall the chemicals at a concentra-
tion of 2 jiM, compared to a mixture of 1
pM ofeach compound. The zr protein anti-
serum in the ELISA analysis gave a higher
response than the vitellogenin antibody.
However, our previous studies revealed a
concentration-dependent and distinct tem-
poral induction of zr proteins and vitel-
logenin when salmon was exposed to
increasing E2 amounts, both in vivo and in
vitro (5). Furthermore, our recent studies of
levels ofzr protein mRNA and vitellogenin
mRNA in liver samples from salmon inject-
ed with increasing amounts of E2 showed
that zr protein mRNAwas induced at lower
levels of E2 than vitellogenin mRNA (29);
this corresponds with the absence or pres-
ence of the respective proteins in the assay
medium observed in the present study.
The in vitrofindings for zr proteins and
vitellogenin at 48 hr and 96 hr exposure,
respectively, are somewhat difficult to com-
pare with previous results from in vivo
experiments (30). Arukwe et al. (30)
reported that o,p'-DDT, BPA, y-HCH,
and Aroclor 1254 injected into Atlantic
salmon in combination with 4-NP did not
elevate the levels of zr proteins or vitel-
logenin after 2 weeks of exposure when
compared to a single treatment with 4-NP
or a mixture ofall the chemicals. However,
these in vivo observations are interpretable
in terms of the present results for zr pro-
teins at 96 hr of exposure. Discrepancies
between in vivo and in vitro experiments
could be due to exposure time, xenobiotic
metabolism, or other factors. However,
both studies demonstrate the complexity of
pinpointing synergistic or additive effects
ofenvironmental chemicals.
ICI 182,780 is a potent and specific
inhibitor of estrogen action, with a relative
binding affinity of0.89, compared to 1.0 for
E2 (31). In our study, ICI 182,780 inhibited
synthesis ofboth zr proteins andvitellogenin
when combined with environmental chemi-
cals (individually or in a mixture) or myco-
toxins. Induction ofzr proteins was onlypar-
tially inhibited when cells were treated with
a-ZEA in combination with ICI 182,780. A
similar result was seen when hepatocytes
were treated with high concentrations ofE2
in combination with inhibitor (data not
shown). ICI 182,780 is a competitive
inhibitor, and incomplete inhibition maybe
due to the strong estrogenicity ofthe a-ZEA
at the concentration used in the present
study. Mechanisms of estrogenic action of
xenoestrogens are complex, but these results
indicate that the ER is involved in this cellu-
lar assay system. Previous studies (32) using
the ER inhibitors tamoxifen and ICI
164,384 showed that synthesis ofboth vitel-
logenin mRNA and ERwere inhibited when
rainbow trout hepatocytes were treated with
E2, lindane, Aroclor 1254, 4-NP, or chlorde-
cone in combination with ERinhibitors.
The present paper demonstrates for the
first time the relative estrogenic effect of
ZEA and its metabolites with regard to
both zonagenesis and vitellogenesis. The
estrogenic potential of ZEA has been
assessed in vivo by uterotropic assays in
rodents (33) and in vitro in human cancer
cell lines such as MCF-7 cells (34); recep-
tor binding studies in, for example, a HeLa
cell co-transfection assay (35); and geneti-
cally transformed mouse cells (36). The
general conclusion from these studies is
that ZEA competes with E2 in the binding
to the cytosolic ER. Our results are in
accordance with previous receptor binding
studies in terms of the relative affinity of
ZEA versus its biologically active metabo-
lites. The observation that a-ZEA is more
potent than ZEA, which in turn is some-
what more potent than P-ZEA, agrees well
with their respective affinities to ER
(37,38). To our knowledge, this is the first
time the estrogenic response ofZEA and its
metabolites have been directly assessed in
vitro. Our study shows that this assay is
capable of detecting estrogen activity of
compounds with widely differing chemical
structure. As seen in Figure 1, chemical
structures of the compounds used in our
study are dissimilar; however, some func-
tional groups are more important then oth-
ers for estrogenic activity. For example, the
para-substituted phenolic group is impor-
tant according toJordan et al. (39).
While human-oriented systems are
helpful in assessing potential ecological
impact ofenvironmental chemicals, few of
the available in vitro assays have specifically
focused on wildlife as opposed to human
risk aspects. Versatile in vitro assays are
valuable for reproductive toxicology. In
vitro assays are relatively inexpensive com-
pared to most in vivo experiments and are
often faster to perform. Zr protein and
vitellogenin in vitro assays are useful to
assess exposure, as well as to study possible
mechanisms of action of xenoestrogens.
This study emphasizes the usefulness of zr
proteins in this respect, and there are some
indications that zr proteins may be more
generally present in other vertebrates (40).
...... j.p : -. h. ..M
J*m0151 o|>''>{>''.S.'S,'',,......~~~~~~~~~~~............,''''''.¢f.
'l. .......... Q1 $g$ S.tS.i .#S$ ....................?R.-
~~~~~~~~~~~~~~~~~~~.2.. ....$. .-.. .. .. .... .... .:.:i....
3 10 ~ ~100hOG00 1000+ICl Control Control +ICl
.....sst s 's .s ' g'1 1?1. i.,~!;~u
.%
imb a g lw i |S|fWIM|2$gd 3 1aa- O'................
*f 0.05_
10 100 1,00 1000 IClControl Control +ICI
0w ;gs E w i ii;,3$; s 1 ms gb e Wsca S:w s s ; ?.22.2.Ss2.t_<.2~~~~~~~~~~~~~if02.;lW......?s
0.2 .."tN:;: r: :;i
0.15 r . ~10 100-1-000 1000+ ICI Control control +iCl
Fiue 7. WB Idcioofvtlgen i n meiu fromg
zearalenone (ZEA), (B) czearalenol (xZA and........
11.S>? ; s t $.$ ? C$ $ ?¢n
(C) O 13-zalenol (13-EA), mesred byenzyme linkedimmunosorbent aa (ElIS) Control Contol + oC
- T H ~~~~(nM)
Figure 7. Induction of vitellogenin in medium from
hepatocytes treated with 10, 100, and 1,000 nM (A)
zearalenone (ZEA), (B) ax-zearalenol (ax-ZEA), and
(C) P-zearalenol (Pi-ZEA), measured by enzyme-
linked immunosorbent assay (ELISA) after 96 hr of
treatment. Cells were also treated with 1 pM ICI
182,780 in combination with 100 nM a-ZEA, orwith
1,000 nM ,B-ZEA orZEA. Data are given as means ±
standard deviations oftriplicate cell treatments.
*p<0.01,**p<0.0041.
In vivo assays provide information about
net effects in whole animals, where xenobi-
otics may act at multiple sites and organs,
while revealing little about the mechanisms
involved. A combination of in vivo experi-
ments and in vitro assays is optimal to
delineate both mechanisms and effects of
xenobiotics as a part ofunderstanding real-
istic risks and gross impact ofenvironmen-
tal chemicals.
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